aclidinium

This page shows the latest aclidinium news and features for those working in and with pharma, biotech and healthcare.

Circassia seeks shift to AIM after failing LSE criteria

The Oxford-based company is buying US commercial rights to AstraZeneca’s chronic obstructive pulmonary disease (COPD) medicine Tudorza (aclidinium bromide), a drug that the two companies have partnered since 2017. ... Duaklir (aclidinium/formoterol)

Latest news

Circassia exits allergy R&D after placebo effect strikes again

Circassia also recently formed a partnership with AstraZeneca (AZ) for the development and commercialisation of two chronic obstructive pulmonary disease (COPD) medicines - Tudorza (aclidinium bromide) and Duaklir (aclidinium bromide/formoterol) in
GSK's triple COPD therapy tops Symbicort in phase III trial

These include GSK's Relvar/Breo (vilanterol/fluticasone furoate) and Anoro (vilanterol/umeclidinium bromide), as well as Novartis' Ultibro (glycopyrronium/indacaterol), AZ's own Duaklir (aclidinium bromide/formoterol fumarate) and Boehringer
GSK brings forward triple COPD therapy filing in US

GSK is jostling for market share with other two-drug combinations, however, including Novartis' Ultibro (glycopyrronium/indacaterol), AstraZeneca's Duaklir (aclidinium bromide/formoterol fumarate) and Boehringer Ingelheim's Spiolto
Boehringer bags FDA approval for Spiriva-based combo

AstraZeneca is also bringing its aclidinium bromide/formoterol fumarate product -sold in Europe as Duaklir - through the latter stages of development.
GSK sees COPD future in triple therapy

Duaklir (formoterol fumarate and aclidinium bromide) jostling for market share.

More from news
Approximately 1 fully matching, plus 27 partially matching documents found.

Latest Intelligence

Interview: Jorge Gallardo, Almirall

We now have five R&D projects about to start or already in phase III and we are intending to register another two projects in 2011: aclidinium bromide for chronic obstructive

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Project Manager/ Account Manager: Salary TBC

PR Director – Health & Wellbeing – Mat Cover (4 days a week)...: Salary TBC

Senior Medical Writer: Salary TBC

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Senior Medical Writer: Up to £50, 000 with Benefits

Account Director, Medical Education: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Digital Account Director: Salary TBC

Senior Planner – Healthcare Advertising – New Role: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Account/ Project Director – Medical Affairs – Surrey: Salary TBC

AD – Corporate Comms/ Public Affairs/ B2B – Healthcare Focus: Salary TBC

Senior Medical Writer: Great salary and benefits

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Project/ Events Manager – Medical Education and Events Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

VCCP Health

We’re the challenger agency for challenger brands. Brands with a point to prove. Rx, OTC and wellness brands run by...

Latest intelligence

International Childhood Cancer Day 2019: The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues: Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...
Mixing up Focus Groups: A nice spread of homogeneous participants in a focus groups are often a go to for reliable research outcomes but there's much to be said for mixing it up and...